Amgen Investor Buys Shares as Earnings Beat and $2.52 Dividend Set
Amgen’s shares saw new institutional buying, with Nilsine Partners acquiring 9,193 shares worth about $3.33M and Saudi Central Bank increasing holdings to 37,735 shares. Azimuth Capital also raised its stake slightly. The company reported quarterly EPS of $6.29, beating estimates, and set a $2.52 dividend. Shares fell 1.6% and insiders sold 6,222 shares over 90 days.